四川大学学报（医学版）2025，Vol.56Issue(3)：633-639,7.DOI:10.12182/20250560110
中西协同糖尿病下肢动脉疾病防治体系的构建
Construction of the Chinese-Western Synergistic System for the Prevention and Treatment of Diabetic Lower Extremity Arterial Disease
摘要
Abstract
Diabetic lower extremity arterial disease(DLEAD)is characterized by a low rate of diagnosis,low awareness,low treatment rate,high disability rate,and high mortality.Due to a lack of comprehensive prevention and treatment strategies or an integrated technological system,DLEAD has become a bottleneck in the prevention and control of diabetes mellitus at present.Traditional Chinese medicine(TCM)treatment of DLEAD offers the advantages of syndrome differentiation,evidence-based treatment,and holistic regulation.However,it lacks a comprehensive understanding of the through-course pathogenesis and unified standardized syndrome criteria.TCM treatment of DLEAD exerts multi-target and multi-pathway network effects,but the advantageous links are still not fully understood.TCM treatments can delay the onset and development of DLEAD,but the efficacy evaluation system remains incomplete.Furthermore,there is a lack of high-quality evidence-based medical evidence and clinical consensus and guidelines.Therefore,based on the idea of zhi wei bing,or treating the disease before it develops,in Chinese medicine,and focusing on the prevention and control of DLEAD,we have constructed a synergistic technical system that integrates traditional Chinese and Western medicine for the prevention and control of DLEAD.This system integrates prevention,diagnosis,treatment,mechanisms,and applications,so as to enhance the clinical effects of DLEAD prevention and control,and to create a new paradigm for collaborative traditional Chinese medicine and western medicine in the field of chronic disease management.关键词
糖尿病下肢动脉疾病/中西医结合/治未病Key words
Diabetic lower extremity arterial disease/Integration of traditional Chinese medicine and western medicine/Preventive treatment of disease引用本文复制引用
高泓,谢红艳,梁清芝,谢春光..中西协同糖尿病下肢动脉疾病防治体系的构建[J].四川大学学报（医学版）,2025,56(3):633-639,7.基金项目
国家中医药管理局中西医协同慢病管理项目(No.CXZH2024094)、国家中医药传承创新团队项目(No.ZYYCXTD-C-202209)、委校联合创新基金-循证专项(No.WXLH202401001)和四川省中医药科技产业创新团队专项(No.2022C012)资助 （No.CXZH2024094）
